Can Reworked Product Be Released? Pass Four Identity, Cause, Reinspection and Traceability Gates

A batch of products has completed rework, and the delivery deadline is approaching. Production claims the dimensions have been corrected, but quality is hesitant to sign off, and warehouse is still urging for inventory entry. The fastest action at this point is to clearly explain each of the four gates.

This inspection process applies to rework, reprocessing, and sorting in discrete manufacturing. The referenced pharmaceutical production regulations are only used as a reference framework for strict quality control and do not imply that all factories are subject to the same regulatory obligations.

Factory owners must first clarify authority, responsibilities, and boundaries. Production is responsible for execution, quality for judgment, and technical positions for approval of methods. When risks arise, whoever accepts ownership, handles, escalates, transfers, or closes the issue must have authorization, and no one should be held solely responsible for reporting.

Is the identity locked?

First, confirm who the reworked product is: work order, product, batch or serial number, original nonconforming quantity, reworked quantity, and unprocessed quantity. Physical labels, isolation areas, and system status must correspond with each other.

When identity is unclear, even if a random sample passes inspection, it cannot be proven that the inspected item was originally nonconforming. If remaining quantities are mixed back into normal products, it will create new traceability gaps.

A hard rule applies on the shop floor: reworked products cannot be moved to 'pending release' without a unique identifier, quantity balance, and current location, to prevent incorrect assignment of inspection results.

Do the cause and action align?

Rework orders cannot simply state 'completed'. They must include the original defect, root cause, approved method, key parameters, allowed number of reworks, and actual actions taken. If the method changes or exceeds the allowed number, a reassessment is required.

The U.S. eCFR's rework provisions for pharmaceuticals require written procedures to ensure that reworked batches meet established standards, and these procedures must be reviewed and approved by the quality control department. General factories can adopt the logic of approving the path before executing the action.

Products can be disposed of before the root cause is clear, but product disposition cannot be equated with closing the root cause. Quality closure and product release must address two distinct questions.

Can re-inspection cover new risks?

Reinspection is not simply repeating the original inspection steps. Machining repairs may alter dimensions, surface finish, and heat-affected zones; welding repairs may introduce deformation and cracks; and repackaging may affect labeling and quantity. The rework action introduces new risks, which determine the scope of reinspection.

The eCFR's release provisions specify sampling methods, number of samples per batch, and acceptance and rejection criteria in procedures, and require reworked materials to still meet applicable conditions before use. General factories can use this to establish their own inspection combinations, rather than ad-hoc sampling of two items.

Reinspection records must clearly document the inspection basis, sample selection method, results, responsible person, and time. For special processes that cannot be fully validated, the focus should return to process parameters, personnel qualifications, and equipment status, rather than relying solely on end-product samples as process evidence.

Is the scope of influence fully traced?

Discovering a single nonconformance does not mean the issue is limited to that single item. Check items produced on the same equipment, with the same tooling, from the same material batch, within the same time window, and of the same product type to identify which objects may share the same root cause, and document the rationale for including or excluding them.

eCFR's production record review provisions require investigation of unexplained discrepancies and extension to potentially related batches, forming conclusions and subsequent actions. For general factories, this means avoiding the recurrence of issues after rework, where the current batch is fixed but the next batch repeats the problem.

Finally, condense the release conclusion into a verifiable statement: the object has been identified, the approval action has been executed, new risks have been re-inspected, and the scope of impact has been assessed. If any of the four items lacks evidence, maintain isolation and clearly define the responsibility and deadline for additional documentation.

Create a one-page checklist for the four gates, fixing the four fields: object, action, re-inspection, and impact scope. Each release should be verified item by item, and weekly reviews should be conducted to identify recurring rework points, ensuring the tool is not just a signature sheet.

Small factories can use a one-page rework release card, medium-sized factories can set up the four gates as electronic sign-off, and mature factories should also link similar issues with changes and customer complaints. Not all factories need the same level of complexity, but the four judgments cannot be replaced by a single 'completed' status.

I am Huang Chaoxing, inventor of the TreeMES stack-light MES system. Follow me for more practical factory-management methods.